{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:56:09Z","timestamp":1789239369139,"version":"build-2803163510"},"reference-count":35,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"4","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JGO"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>The United Nations Sustainable Development Goals 2015 to 2030 includes a specific goal for health (Sustainable Development Goal [SDG] 3) with 13 targets, including SDG3.4 for the control and treatment of noncommunicable diseases (NCDs), namely, cardiovascular diseases, cancer, diabetes, and chronic lung disease. There is considerable concern that SDG3.4 may not be achieved. The WHO Best Buys for NCDs has emphasized prevention, and although crucial, it alone will not achieve the 30% reduction in NCDs by 2030. Likewise, a strengthened health system is required as all NCDs are likely to require hospital facilities and community services for optimal management. This is a major problem for low-resource countries (LRCs) \u2014that is, low-income countries and lower-middle-income countries\u2014as most currently have a poorly developed health system, including cancer services, in need of upgrading. This is a result of the extreme poverty of LRCs, where 40% to 80% of the population live on less than USD $1.25 per day, with the average health spending by governments in low-income countries at $110 per person per year. In this article, we outline a comprehensive national cancer services plan for LRCs. Surgery, radiotherapy, and chemotherapy for cancer treatment also require input from other specialties, such as anesthesia, pathology, laboratory medicine, a blood bank, and diagnostic radiology. This will provide a focus for adding additional specialties, including cardiology, respiratory medicine, and psychiatry, to support the management of all NCDs and to contribute to the overall strengthening of the health system. The national cancer services plan for LRCs will require significant funding and input from both in-country and overseas experts in health, cancer, and finance working collaboratively. Success will depend on thoughtful strategic planning and providing the right balance of overseas support and guidance, but ensuring that there is in-country ownership and control of the program is essential.<\/jats:p>","DOI":"10.1200\/jgo.18.00185","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T12:34:49Z","timestamp":1544099689000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":9,"title":["Improving Health and Cancer Services in Low-Resource Countries to Attain the Sustainable Development Goals Target 3.4 for Noncommunicable Diseases"],"prefix":"10.1200","author":[{"given":"Graeme W.","family":"Morgan","sequence":"first","affiliation":[{"name":"Graeme W. Morgan, Kirsty Foster, and Vu Huynh, The University of Sydney; Craig Opie, Royal North Shore Hospital, Sydney, New South Wales; and Brendan Healy, Icon Cancer Group, Brisbane, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Foster","sequence":"additional","affiliation":[{"name":"Graeme W. Morgan, Kirsty Foster, and Vu Huynh, The University of Sydney; Craig Opie, Royal North Shore Hospital, Sydney, New South Wales; and Brendan Healy, Icon Cancer Group, Brisbane, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Healy","sequence":"additional","affiliation":[{"name":"Graeme W. Morgan, Kirsty Foster, and Vu Huynh, The University of Sydney; Craig Opie, Royal North Shore Hospital, Sydney, New South Wales; and Brendan Healy, Icon Cancer Group, Brisbane, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Opie","sequence":"additional","affiliation":[{"name":"Graeme W. Morgan, Kirsty Foster, and Vu Huynh, The University of Sydney; Craig Opie, Royal North Shore Hospital, Sydney, New South Wales; and Brendan Healy, Icon Cancer Group, Brisbane, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu","family":"Huynh","sequence":"additional","affiliation":[{"name":"Graeme W. Morgan, Kirsty Foster, and Vu Huynh, The University of Sydney; Craig Opie, Royal North Shore Hospital, Sydney, New South Wales; and Brendan Healy, Icon Cancer Group, Brisbane, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B2","volume-title":"Appendix A: Noncommunicable diseases SDG Target 3.4. World Health Statistics 2016, p 60. Monitoring health for the SDGs","author":"World Health Organization","year":"2016"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1596\/9730","volume-title":"WHO Framework Convention on Tobacco Control","author":"World Health Organization","year":"2003"},{"key":"B5","volume-title":"WHO Global Strategy to Reduce the Harmful Use of Alcohol","author":"World Health Organization","year":"2010"},{"key":"B6","volume-title":"WHO Global Strategy on Diet, Physical Activity and Health","author":"World Health Organization","year":"2004"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31258-3"},{"key":"B11","volume-title":"Comprehensive Cervical Cancer Control: A Guide to Essential Practice","author":"World Health Organization","year":"2006"},{"key":"B12","volume-title":"Comprehensive Cervical Cancer Control: A Guide to Essential Practice","author":"World Health Organization","year":"2014","edition":"2"},{"key":"B13","volume-title":"World Health Statistics 2015: Part II. Global Health Indicators, Table 9","author":"World Health Organization","year":"2016"},{"key":"B15","unstructured":"World Health Organization: World Health Statistics 2015:Part II. Global Health Indicators, Table 7. World Health Organization, Geneva, Switzerland. 2016, p 134"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70213-X"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00222-3"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60160-X"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.2016.005454"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30458-6"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPQ5KTKAGSSCFN"},{"key":"B23","first-page":"15","volume":"147","author":"Fleming KA","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181c17fe6"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPYPDES6Z8ELEY"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-013-2324-y"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70349-3"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00223-5"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2016.03.002"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt498"},{"key":"B32","volume-title":"Countering the problem of falsified and substandard drugs","author":"Institute of Medicine","year":"2013"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7381"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70279-7"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0346-8_ch4"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70012-4"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61460-3"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00012-7"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czh006"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60233-4"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70288-8"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601705"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.10.031"}],"container-title":["Journal of Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JGO.18.00185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:47:08Z","timestamp":1775296028000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JGO.18.00185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1200\/JGO.18.00185"],"URL":"https:\/\/doi.org\/10.1200\/jgo.18.00185","relation":{},"ISSN":["2378-9506"],"issn-type":[{"value":"2378-9506","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"2018-11-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}